| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 02/03/2005 | US20050026927 Pyrazole derivatives as psychopharmaceuticals |
| 02/03/2005 | US20050026926 N, N'-disubstituted piperazine compounds and their use as analgesics |
| 02/03/2005 | US20050026915 As melanin concentrating hormone (MCH)receptor antagonists, for prevention or treatment of obesity or eating disorders; (2E)-3-(4-chlorophenyl)-N-[2-(dimethylamino)quinolin-6-yl]prop-2-enamide |
| 02/03/2005 | US20050026908 Can bind to Prostaglandin E2 receptors, especially, EP3 receptor and/or EP4 receptor and show antagonizing activity, and may be useful for prevention and/or treatment of disease, for example, pain, allergy, Alzheimer's disease, cancer |
| 02/03/2005 | US20050026904 Cathepsin S, K, F, L and B reversible inhibitory amidino and guanidino peptidyl compounds useful for treating autoimmune diseases, rheumatoid arthritis, multiple sclerosis, asthma and osteoporosis |
| 02/03/2005 | US20050026889 Treating acne, seborrhea, hirsutism, alopecia, mastodynia, prostate hyperplasia and carcinoma, virilization syndromes in the female, early puberty, use in inhibition of sexual aggressiveness in the male, male contraception |
| 02/03/2005 | US20050026885 Administering during follicular phase in a dosage less than an ovulation-inhibiting or abortion-inductive dose; 11 beta -[(4-N,N-Dimethylamino) -phenyl]-17 beta -hydroxy-17 alpha -propinyl-4,9(10)-estradien-3-one (RU 38486) for example; will not abort previously implanted fetus |
| 02/03/2005 | US20050026875 Treating bacterial, viral, or fungal infections, cancer, a lung injury, an eye disorder, neurological disorder or stroke |
| 02/03/2005 | US20050026822 Human 3 relaxin |
| 02/03/2005 | US20050026251 Netrin receptor protein for use in identification of modulator for use in treatment and prevention of infection, nervous system, autoimmune, inflammatory, psycological and reproductive disorders |
| 02/03/2005 | US20050025806 A silicone support of methylvinylsiloxane polymer including a fumed silca reinforcement filler; growth and/or reproduction-associated drug, derivative or analogue and carrier; each implant of insufficient size and/or payload for the predetermined threshold blood level of indicated drug; high-speed |
| 02/03/2005 | US20050025751 Increased or reduced expression of tumor necrosis factors or interleukins; antiinflammatory agents; autoimmune diseases |
| 02/03/2005 | CA2533101A1 Dispersible formulation of an anti-inflammatory agent |
| 02/02/2005 | EP1502601A1 Use of neurotoxin therapy for treatment of urinary retention |
| 02/02/2005 | EP1502600A1 Use of botulinum toxin for treating smooth muscle disorders |
| 02/02/2005 | EP1502590A1 Heterocyclic oxime derivatives, process for their preparation and use thereof in the treatment of type II diabetes |
| 02/02/2005 | EP1501919A1 Soya cell strains with high isoflavone content |
| 02/02/2005 | EP1501859A1 17a-FLUOROALKYL-11BETA-BENZALDOXIME-STEROIDS, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING SAID STEROIDS AND THE USE THEREOF IN THE PRODUCTION OF MEDICAMENTS |
| 02/02/2005 | EP1501835A2 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 02/02/2005 | EP1501834A1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors |
| 02/02/2005 | EP1501830A1 7-aryl-3,9-diazabicyclo[3.3.1]non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases |
| 02/02/2005 | EP1501826A2 Substituted indoles as alpha-1 agonists |
| 02/02/2005 | EP1501819A1 Estrogen receptor modulators |
| 02/02/2005 | EP1501817A1 Imidazolinylmethyl aralkylsulfonamides |
| 02/02/2005 | EP1501807A1 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists |
| 02/02/2005 | EP1501800A1 Bombesin antagonists |
| 02/02/2005 | EP1501515A1 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 02/02/2005 | EP1501512A2 4-azasteroid derivatives as androgen receptor modulators |
| 02/02/2005 | EP1501482A1 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease |
| 02/02/2005 | EP1501478A1 Warming and nonirritating anhydrous lubricant compositions |
| 02/02/2005 | EP1390365B1 Novel sulfonate substituted pyrazol pyridine dervivatives |
| 02/02/2005 | EP1379257A4 Prodrugs of anticancer agents employing substituted aromatic acids |
| 02/02/2005 | EP1303521B1 Tetrahydro-heterocycloazepinyl pyrimidine derivatives |
| 02/02/2005 | EP1303506B1 6-heteroarylphenanthridines |
| 02/02/2005 | CN1575338A Bv8 nucleic acids and polypeptides with mitogenic activity |
| 02/02/2005 | CN1575334A Pathogen for bacterial poultry disease |
| 02/02/2005 | CN1575291A Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist |
| 02/02/2005 | CN1575289A 6-hydroxy isoflavon compounds, their derivatives and medicaments involving the same |
| 02/02/2005 | CN1575182A Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 02/02/2005 | CN1575176A Process for making substituted pyrazoles |
| 02/02/2005 | CN1572792A Pyrazolo [4, 3-d] pyrimidine derivatives |
| 02/02/2005 | CN1572313A Chinese patent medicine for treating vaginal bleeding after medicinal abortion operation and its preparation method |
| 02/02/2005 | CN1187369C Method for producing peptide salts. their use, and pharmaceutical prepns. containing these peptide salts |
| 02/02/2005 | CN1187358C Tetrahydro-heterocyclozaepinyl pyrimidine derivatives |
| 02/02/2005 | CN1187342C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 02/02/2005 | CN1187336C New imidazole derivatives |
| 02/02/2005 | CN1187072C Medicine composition for treating gynaecology inflammation and its preparation method |
| 02/02/2005 | CN1187051C Xanthine-based compound for preparation of medicine for enhancing insulin action |
| 02/02/2005 | CN1187042C Plaster which contains steroids and its production method and uses |
| 02/01/2005 | US6849733 Compounds containing amidated guanidine derivative type functional group of structure N-C(=N)-N-CO-N-C=N or N-C(=N)-N-CO-N |
| 02/01/2005 | US6849653 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 02/01/2005 | US6849635 Sulfonamides |
| 02/01/2005 | US6849421 Nucleotide sequences coding enzymatic polypeptide for the use in the treatment of nervous system disorders |
| 01/27/2005 | WO2005007166A1 Treatment of sexual dysfunction |
| 01/27/2005 | WO2005007150A2 Method for inhibiting protein synthesis in sperm |
| 01/27/2005 | WO2005007102A2 Phytochemicals for the treatment of mastalgia, endometriosis and hpv-related conditions including cervical dysplasia |
| 01/27/2005 | WO2005006899A1 Treatment of male sexual dysfunction |
| 01/27/2005 | WO2004082686A3 Use of compounds with combined 5-ht1a and ssri activities to treat sexual dysfunction |
| 01/27/2005 | WO2003076565A3 Methods of using 46828, a human acyl-coa synthetase |
| 01/27/2005 | US20050020691 Pharmaceutical preparations comprising substituted beta-aminoalcohols |
| 01/27/2005 | US20050020684 Modulators of peroxisome proliferator activated receptors |
| 01/27/2005 | US20050020604 5-HT receptor ligands and uses thereof |
| 01/27/2005 | US20050020584 Benzamide derivatives as antagonists of orexin receptors |
| 01/27/2005 | US20050020573 5HT2c receptor modulators |
| 01/27/2005 | US20050020562 Drugs; analgesics; anesthetics; antiarrhythmia agents; antiinflammatory agents ; incontinence; gastrointestinal disorders; neurodegenerative disease |
| 01/27/2005 | US20050020553 Administering a steroid; diagnosis of pregnancy |
| 01/27/2005 | US20050020541 Moderate neurotransmitters |
| 01/27/2005 | US20050020519 Increase concentration of peptide; controlling glucose uptake into cells; adjust metabolism; stimulate cell proliferation; reduce apoptosis; moderate gene expression' |
| 01/27/2005 | US20050020492 Melanin-concentrating hormone analogs |
| 01/27/2005 | US20050020489 Use of hcg and lh in controlled ovarian hyperstimulation |
| 01/27/2005 | US20050020481 Ion channel modulating compounds and uses thereof |
| 01/27/2005 | US20050019858 Novel human cytokine/steroid receptor protein |
| 01/27/2005 | US20050019765 Methods for treating disorders of the nervous and reproductive systems |
| 01/27/2005 | US20050019763 Isolated polypeptide of given sequence; expression vectors, host cells, antibodies, agonists, and antagonists; use in diagnosing, treating, or preventing various disorders |
| 01/27/2005 | US20050019438 Nutraceuticals for treating physiological disorders related to perimonopause or menopause such as hot flashes; phytoestrogens |
| 01/27/2005 | US20050019437 Administering a photoestrogen for treating urinary bladder infection and dry vagina; plant extracts is obtained from solvent extraction |
| 01/27/2005 | US20050019408 time-release agents comprising water-swellable matrix cores containing estrogen derivative extracted from animals surrounded by film-forming coatings |
| 01/27/2005 | US20050019378 Transdermal drug delivery system of strychnine, brucine, securinine and their salts |
| 01/27/2005 | US20050019367 Continuous release of luteinizing hormone releasing hormone (lh-rh) analogue of leuprorelin, buserelin, triptorelin, and/or goserelin |
| 01/27/2005 | US20050019339 Forming antibodies that recognize epitopes in nature protein; antigen encapsulated in liposomes |
| 01/27/2005 | CA2771944A1 Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
| 01/27/2005 | CA2533177A1 Treatment of male sexual dysfunction |
| 01/27/2005 | CA2532252A1 Treatment of sexual dysfunction |
| 01/26/2005 | EP1500643A1 Benzamide derivatives |
| 01/26/2005 | EP1499746A1 Method to inhibit cell growth using oligonucleotides |
| 01/26/2005 | EP1499726A1 Chimeric camp factors for vaccination against streptococcus infection |
| 01/26/2005 | EP1499631A2 Rna interference mediated inhibition of tgf-beta and tgf-beta receptor gene expression using short interfering nucleic acid (sina) |
| 01/26/2005 | EP1499601A1 New 2-substituted -1,3-thiazole compounds |
| 01/26/2005 | EP1499599A1 Substituted pyrazine derivatives |
| 01/26/2005 | EP1499588A1 Melanocortin receptor ligands |
| 01/26/2005 | EP1499360A2 Formulation comprising buprenorphine |
| 01/26/2005 | EP1499352A1 Recombinant anti-interleukin-9 antibodies |
| 01/26/2005 | EP1499345A2 Protein a compositions and methods of use |
| 01/26/2005 | EP1499336A2 Protease inhibitors |
| 01/26/2005 | EP1499323A1 Treatment of hypertension in women receiving hormone replacement therapy |
| 01/26/2005 | EP1499322A1 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
| 01/26/2005 | EP1499314A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders |
| 01/26/2005 | EP1499290A1 Warming and nonirritating lubricant compositions |
| 01/26/2005 | EP1499288A1 Apparatus and method for delivery of bacteria to the vaginal tract |
| 01/26/2005 | EP1499284A1 Biologically active compounds for the modification of bodily odours |